Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Overall Structures of Mycobacterium tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity.

Petrella S, Capton E, Raynal B, Giffard C, Thureau A, Bonneté F, Alzari PM, Aubry A, Mayer C.

Structure. 2019 Apr 2;27(4):579-589.e5. doi: 10.1016/j.str.2019.01.004. Epub 2019 Feb 7.

PMID:
30744994
2.

Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.

Brossier F, Boudinet M, Jarlier V, Petrella S, Sougakoff W.

Tuberculosis (Edinb). 2016 Sep;100:15-24. doi: 10.1016/j.tube.2016.06.002. Epub 2016 Jun 16.

3.

Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.

Pantel A, Petrella S, Veziris N, Matrat S, Bouige A, Ferrand H, Sougakoff W, Mayer C, Aubry A.

J Antimicrob Chemother. 2016 Sep;71(9):2428-31. doi: 10.1093/jac/dkw169. Epub 2016 May 27.

PMID:
27234461
4.

Perceived ethnic discrimination and persecutory paranoia in individuals at ultra-high risk for psychosis.

Shaikh M, Ellett L, Dutt A, Day F, Laing J, Kroll J, Petrella S, McGuire P, Valmaggia LR.

Psychiatry Res. 2016 Jul 30;241:309-14. doi: 10.1016/j.psychres.2016.05.006. Epub 2016 May 12.

PMID:
27232552
5.

Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays.

Bedini A, Garlassi E, Stentarelli C, Petrella S, Meacci M, Meccugni B, Meschiari M, Franceschini E, Cerri S, Brasacchio A, Rumpianesi F, Richeldi L, Mussini C.

New Microbes New Infect. 2016 Apr 7;12:45-51. doi: 10.1016/j.nmni.2016.03.010. eCollection 2016 Jul.

6.

Impaired prefrontal synaptic gain in people with psychosis and their relatives during the mismatch negativity.

Ranlund S, Adams RA, Díez Á, Constante M, Dutt A, Hall MH, Maestro Carbayo A, McDonald C, Petrella S, Schulze K, Shaikh M, Walshe M, Friston K, Pinotsis D, Bramon E.

Hum Brain Mapp. 2016 Jan;37(1):351-65. doi: 10.1002/hbm.23035. Epub 2015 Oct 27.

7.

Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion.

Agrawal A, Roué M, Spitzfaden C, Petrella S, Aubry A, Hann M, Bax B, Mayer C.

Biochem J. 2013 Dec 1;456(2):263-73. doi: 10.1042/BJ20130538.

PMID:
24015710
8.

Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes.

Bouige A, Darmon A, Piton J, Roue M, Petrella S, Capton E, Forterre P, Aubry A, Mayer C.

Biochem J. 2013 Nov 1;455(3):285-94. doi: 10.1042/BJ20130430.

PMID:
23869946
9.

Interactive effects in transfer-appropriate processing for event-based prospective memory: the roles of effort, ongoing task, and PM cue properties.

Abney DH, McBride DM, Petrella SN.

Mem Cognit. 2013 Oct;41(7):1032-45. doi: 10.3758/s13421-013-0324-7.

PMID:
23649838
10.

Yellow fever epizootics in non-human primates, São Paulo state, Brazil, 2008-2009.

Moreno ES, Spinola R, Tengan CH, Brasil RA, Siciliano MM, Coimbra TL, Silveira VR, Rocco IM, Bisordi I, Souza RP, Petrella S, Pereira LE, Maeda AY, Silva FG, Suzuki A.

Rev Inst Med Trop Sao Paulo. 2013 Jan-Feb;55(1):45-50.

11.

New mutations in the mycobacterial ATP synthase: new insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure.

Segala E, Sougakoff W, Nevejans-Chauffour A, Jarlier V, Petrella S.

Antimicrob Agents Chemother. 2012 May;56(5):2326-34. doi: 10.1128/AAC.06154-11. Epub 2012 Feb 21.

12.

Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase CTD.

Darmon A, Piton J, Roué M, Petrella S, Aubry A, Mayer C.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Feb 1;68(Pt 2):178-80. doi: 10.1107/S1744309111051888. Epub 2012 Jan 26.

13.

Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.

Pantel A, Petrella S, Veziris N, Brossier F, Bastian S, Jarlier V, Mayer C, Aubry A.

Antimicrob Agents Chemother. 2012 Apr;56(4):1990-6. doi: 10.1128/AAC.06272-11. Epub 2012 Jan 30.

14.

DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.

Pantel A, Petrella S, Matrat S, Brossier F, Bastian S, Reitter D, Jarlier V, Mayer C, Aubry A.

Antimicrob Agents Chemother. 2011 Oct;55(10):4524-9. doi: 10.1128/AAC.00707-11. Epub 2011 Jul 18.

15.

Isolation of yellow fever virus (YFV) from naturally infected Haemagogus (Conopostegus) leucocelaenus (diptera, cukicudae) in São Paulo State, Brazil, 2009.

Souza RP, Petrella S, Coimbra TL, Maeda AY, Rocco IM, Bisordi I, Silveira VR, Pereira LE, Suzuki A, Silva SJ, Silva FG, Salvador FS, Tubaki RM, Menezes RT, Pereira M, Bergo ES, Hoffmann RC, Spinola RM, Tengan CH, Siciliano MM.

Rev Inst Med Trop Sao Paulo. 2011 May-Jun;53(3):133-9.

16.

Crystal structure of the pyrazinamidase of Mycobacterium tuberculosis: insights into natural and acquired resistance to pyrazinamide.

Petrella S, Gelus-Ziental N, Maudry A, Laurans C, Boudjelloul R, Sougakoff W.

PLoS One. 2011 Jan 24;6(1):e15785. doi: 10.1371/journal.pone.0015785.

17.

Structural insights into the quinolone resistance mechanism of Mycobacterium tuberculosis DNA gyrase.

Piton J, Petrella S, Delarue M, André-Leroux G, Jarlier V, Aubry A, Mayer C.

PLoS One. 2010 Aug 18;5(8):e12245. doi: 10.1371/journal.pone.0012245.

18.

Conservation of HHV-6 DNA polymerase processivity factor sequence and predicted structure suggests it as a target for antiviral development.

Bonnafous P, Verbelen M, Petrella S, Deback C, Gautheret-Dejean A, Boutolleau D, Naesens L, Agut H.

Antiviral Res. 2010 Jun;86(3):316-9. doi: 10.1016/j.antiviral.2010.03.005. Epub 2010 Mar 16.

PMID:
20298721
19.

Specific structural features of the N-acetylmuramoyl-L-alanine amidase AmiD from Escherichia coli and mechanistic implications for enzymes of this family.

Kerff F, Petrella S, Mercier F, Sauvage E, Herman R, Pennartz A, Zervosen A, Luxen A, Frère JM, Joris B, Charlier P.

J Mol Biol. 2010 Mar 19;397(1):249-59. doi: 10.1016/j.jmb.2009.12.038. Epub 2009 Dec 28.

PMID:
20036252
20.

Detection of a new yellow fever virus lineage within the South American genotype I in Brazil.

de Souza RP, Foster PG, Sallum MA, Coimbra TL, Maeda AY, Silveira VR, Moreno ES, da Silva FG, Rocco IM, Ferreira IB, Suzuki A, Oshiro FM, Petrella SM, Pereira LE, Katz G, Tengan CH, Siciliano MM, Dos Santos CL.

J Med Virol. 2010 Jan;82(1):175-85. doi: 10.1002/jmv.21606.

PMID:
19950229
21.

Purification, crystallization and preliminary X-ray diffraction experiments on the breakage-reunion domain of the DNA gyrase from Mycobacterium tuberculosis.

Piton J, Matrat S, Petrella S, Jarlier V, Aubry A, Mayer C.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Nov 1;65(Pt 11):1182-6. doi: 10.1107/S1744309109042067. Epub 2009 Oct 30.

22.

Crystal structure and activity of Bacillus subtilis YoaJ (EXLX1), a bacterial expansin that promotes root colonization.

Kerff F, Amoroso A, Herman R, Sauvage E, Petrella S, Filée P, Charlier P, Joris B, Tabuchi A, Nikolaidis N, Cosgrove DJ.

Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16876-81. doi: 10.1073/pnas.0809382105. Epub 2008 Oct 29.

23.

Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France.

Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W.

Antimicrob Agents Chemother. 2008 Oct;52(10):3725-36. doi: 10.1128/AAC.00163-08. Epub 2008 Jul 14.

24.

Molecular characterization of two Rocio flavivirus strains isolated during the encephalitis epidemic in São Paulo State, Brazil and the development of a one-step RT-PCR assay for diagnosis.

Coimbra TL, Santos RN, Petrella S, Nagasse-Sugahara TK, Castrignano SB, Santos CL.

Rev Inst Med Trop Sao Paulo. 2008 Mar-Apr;50(2):89-94.

25.

Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.

Bonnafous P, Naesens L, Petrella S, Gautheret-Dejean A, Boutolleau D, Sougakoff W, Agut H.

Antivir Ther. 2007;12(6):877-88.

PMID:
17926642
26.

Mayaro virus: imported cases of human infection in São Paulo State, Brazil.

Coimbra TL, Santos CL, Suzuki A, Petrella SM, Bisordi I, Nagamori AH, Marti AT, Santos RN, Fialho DM, Lavigne S, Buzzar MR, Rocco IM.

Rev Inst Med Trop Sao Paulo. 2007 Jul-Aug;49(4):221-4.

27.

Crystal structure of the Bacillus subtilis penicillin-binding protein 4a, and its complex with a peptidoglycan mimetic peptide.

Sauvage E, Duez C, Herman R, Kerff F, Petrella S, Anderson JW, Adediran SA, Pratt RF, Frère JM, Charlier P.

J Mol Biol. 2007 Aug 10;371(2):528-39. Epub 2007 Jun 2.

28.

Expression and purification of an active form of the Mycobacterium leprae DNA gyrase and its inhibition by quinolones.

Matrat S, Petrella S, Cambau E, Sougakoff W, Jarlier V, Aubry A.

Antimicrob Agents Chemother. 2007 May;51(5):1643-8. Epub 2007 Feb 26.

29.

Genetic basis for natural and acquired resistance to the diarylquinoline R207910 in mycobacteria.

Petrella S, Cambau E, Chauffour A, Andries K, Jarlier V, Sougakoff W.

Antimicrob Agents Chemother. 2006 Aug;50(8):2853-6.

30.

Characterization of the chromosomal class A beta-lactamase CKO from Citrobacter koseri.

Petrella S, Renard M, Ziental-Gelus N, Clermont D, Jarlier V, Sougakoff W.

FEMS Microbiol Lett. 2006 Jan;254(2):285-92.

31.

St. Louis encephalitis virus: first isolation from a human in São Paulo State, Brazil.

Rocco IM, Santos CL, Bisordi I, Petrella SM, Pereira LE, Souza RP, Coimbra TL, Bessa TA, Oshiro FM, Lima LB, Cerroni MP, Marti AT, Barbosa VM, Katz G, Suzuki A.

Rev Inst Med Trop Sao Paulo. 2005 Sep-Oct;47(5):281-5. Epub 2005 Nov 16.

32.

Crystal structure of the Actinomadura R39 DD-peptidase reveals new domains in penicillin-binding proteins.

Sauvage E, Herman R, Petrella S, Duez C, Bouillenne F, Frère JM, Charlier P.

J Biol Chem. 2005 Sep 2;280(35):31249-56. Epub 2005 Jun 29.

33.

Crystallization and preliminary X-ray diffraction study of the class A beta-lactamase SED-1 and its mutant SED-G238C from Citrobacter sedlakii.

Petrella S, Pernot L, Sougakoff W.

Acta Crystallogr D Biol Crystallogr. 2004 Jan;60(Pt 1):125-8. Epub 2003 Dec 18.

PMID:
14684905
34.

Yeast metallothionein in transgenic tobacco promotes copper uptake from contaminated soils.

Thomas JC, Davies EC, Malick FK, Endreszl C, Williams CR, Abbas M, Petrella S, Swisher K, Perron M, Edwards R, Osenkowski P, Urbanczyk N, Wiesend WN, Murray KS.

Biotechnol Prog. 2003 Mar-Apr;19(2):273-80. Erratum in: Biotechnol Prog. 2004 Jan-Feb;20(1):402. Osenkowski, Pam [correction of Ostenkowski, Pam].

PMID:
12675559
35.

Crystal structures of the class D beta-lactamase OXA-13 in the native form and in complex with meropenem.

Pernot L, Frénois F, Rybkine T, L'Hermite G, Petrella S, Delettré J, Jarlier V, Collatz E, Sougakoff W.

J Mol Biol. 2001 Jul 20;310(4):859-74.

PMID:
11453693
36.

Novel class A beta-lactamase Sed-1 from Citrobacter sedlakii: genetic diversity of beta-lactamases within the Citrobacter genus.

Petrella S, Clermont D, Casin I, Jarlier V, Sougakoff W.

Antimicrob Agents Chemother. 2001 Aug;45(8):2287-98.

37.

A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group.

Bellentani S, Baldoni P, Petrella S, Tata C, Armocida C, Marchegiano P, Saccoccio G, Manenti F.

Fam Pract. 1990 Dec;7(4):307-12.

PMID:
2289644

Supplemental Content

Loading ...
Support Center